TNNI3 and myocardial infarction: A recent individual patient-level meta-analysis in 22,457 patients further demonstrated that a hs-cTnI concentration < 5 ng/L at presentation yields a NPV as high as 99.5% for MI or cardiac death at 30 days (6).